Skip to search formSkip to main contentSkip to account menu

IM 862

Known as: IM-862, IM862 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

oglufanide disodium
thymogen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Der Angiogenese-Inhibitor IM862 verbessert das Überleben beim experimentellen Pankreaskarzinom auch nach verzögertem Therapiebeginn
IM862 is a dipeptide of L-glutamyl-L-tryptophan with antiangiogenic properties and potential antitumor activity. This study… 
2008
2008
Angiogenesehemmung und Gemcitabine beim experimentellen Pankreaskarzinom — einer alleinigen Chemotherapie überlegen?
The effect of antiangiogenetic monotherapy on experimental pancreatic cancer is limited. Therefore this study evaluated the… 
2007
2007
Enhancement of oral drug absorption-effect of lipid conjugation on the enzymatic stability and intestinal permeability of l-Glu-l-Trp-NH(2).
2007
2007
Employing the treatment‐free interval of intermittent androgen ablation to screen candidate prostate cancer therapies
Because neither continuous nor intermittent hormonal therapy is curative, we designed a clinical model to screen new drugs for… 
2007
2007
Enhancement of Oral Drug Absorption - Effect of Lipid and Glycoside Conjugation on the Enzymatic Stability and Intestinal Permeability of IM862
IM862 is a naturally occurring thymic dipeptide L-Glu-L-Trp‚ which has been shown to possess immuno-modulating and anti… 
2006
2006
Phase II Trial of the Antiangiogenic Agent IM862 in Metastatic Renal Cell Carcinoma
2004
2004
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma
IM862 is a naturally occurring dipeptide (L-glu-L-trp) with immunomodulatory and antiangiogenic properties. A significant… 
2004
2004
Der Angiogenese-Inhibitor IM862 verbessert das Oberleben beim experimentellen Pankreaskarzinom auch nach verzogertem Therapiebeginn The angiogenesis inhibitor IM862 increases survival in pancreatic…
IM862isadipeptideofL-glutamyl-L-tryptophanwithantiangiogenicpropertiesandpotentialanti­ tumoractivity… 
Highly Cited
2000
Highly Cited
2000
Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma.
PURPOSE Although advances have been made in the treatment of AIDS-related Kaposi's sarcoma (AIDS-KS) with systemic chemotherapy… 
Review
2000
Review
2000
[Recent studies on anti-angiogenesis in cancer therapy].
Angiogenesis is known to be a critical process for the tumor growth and metastasis. There are many indigenous role-players in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)